UBS assumes coverage on StepStone stock with buy rating, $60 target

UBS initiated coverage on StepStone (STEP) with a Buy and $60 price target while the stock trades at $46.99, ~40% below its $77.80 52-week high. StepStone reported Q3 FY2026 adjusted net income of $80M ($0.65) vs $53M ($0.44) a year ago, but a GAAP net loss of $123M ($1.55); the Board authorized a share repurchase program up to $100M. Goldman Sachs raised its price target to $93 (from $90) citing a $16B Private Wealth franchise and >$2B expected quarterly subscriptions, and UBS projects ~20% fee-related EPS CAGR to 2028 with FY27/FY28 EPS estimates of $2.53 and $3.31 (6–8% above consensus).

Analysis

StepStone’s public valuation should be read as a premium-on-optionalities story rather than a pure fee-growth multiple: the core optionality is integration and monetization of distribution technology that converts episodic private market returns into steadier fee streams. If management can shift 200–400 bps of asset mix from performance/realization-dependent fees to recurring wealth fees over 12–24 months, the market will re-rate governance and predictability rather than raw assets under management, compressing perceived risk premia for the stock.

The primary structural risk is mismatch between illiquid private assets and liquid public equity — headline GAAP volatility will continue to generate outsized flow reactions absent clearer cash conversion signals. Macro shocks (rates up, public valuations down) will accelerate write-downs in portfolio NAVs and can erase realized fee momentum within a single quarter; expect the company to be sensitive to PE multiple compression and to discretionary realizations on a 3–9 month cadence.

Second-order winners include boutique wealth platforms and fintech distributors that can white-label private-alternatives access; incumbents that can replicate proprietary data will face higher go-to-market costs and potential margin erosion. Conversely, private-credit–heavy managers are the most exposed if liquidity/valuation shocks occur, creating a cheap and natural hedge against an alternatives-sector downcycle.

Putting it together: this is a 12–24 month trade on execution of distribution and margin conversion, not a near-term earnings beat. Volatility will remain elevated around quarterly releases, so structure exposure to favor convex upside (options/call-spreads) or use pairs to neutralize sector beta while keeping idiosyncratic upside exposure.

Key Decisions for Investors

• Directional structured long: Buy STEP via a 12–18 month call spread sized at 3–5% portfolio. Target entry: after next quarter release when adjusted vs GAAP noise peaks (within 2–6 weeks post-release). Structure: long 25–35% OTM calls, short 60–75% OTM calls. Risk/Reward: limited premium (loss = premium) with 2–4x upside if the market re-rates over 12–24 months.
• Pair trade (reduce sector beta): Long STEP equity (size 2–3%) / Short KKR (KKR) or another private-credit-heavy manager (size 1–1.5%) over 6–12 months. Rationale: isolates distribution/margin conversion upside in STEP while hedging industry-wide valuation shocks. Risk/Reward: aims for asymmetric return if STEP’s recurring-fee mix re-accelerates; downside capped by pair size and stop-loss at 15–20% on the net position.
• Volatility hedge: Buy 3–6 month protective puts on STEP equal to ~50–60% of the equity position prior to earnings windows. Rationale: protects against headline-driven intraday/weekly drops from NAV/GAAP surprises. Cost: pay premium; benefit is convex downside protection during high-volatility quarters.
• Short candidate as hedge: Initiate a small short on a private-credit-centric manager or ETF (size 1%) to capture downside in performance-fee compression if rates spike. Timeframe: 3–9 months. Risk/Reward: limited notional; expected payoff if realizations and markdowns accelerate, providing a hedge to STEP exposure that is tied more to recurring wealth flows than credit marks.